Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin

Pharmacology

Volumn 70, Issue 2, 2004, Pages 59-67

  Naidu, Pattipati S ^a   Singh, Amanpreet ^a   Kulkarni, Shrinivas K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Memory; Oxidative stress; Quercetin; Reserpine; Tardive dyskinesia; VCMs

Indexed keywords

CATALASE; GLUTATHIONE; QUERCETIN; RESERPINE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; LIPID PEROXIDATION; MALE; MASTICATION; MAZE TEST; MEMORY CONSOLIDATION; MEMORY DISORDER; NONHUMAN; OROFACIAL DYSKINESIA; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; TONGUE;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BLOOD PROTEINS; CATALASE; COGNITION DISORDERS; DYSKINESIA, DRUG-INDUCED; GLUTATHIONE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MAZE LEARNING; QUERCETIN; RATS; RESERPINE; SUPEROXIDE DISMUTASE; TRANSFER (PSYCHOLOGY);

EID: 0347418243     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074669     Document Type: Article

References (67)

1. Casey DE: Tardive dyskinesia: Pathophysiology and animal models. J Clin Psychiat 2000;61: 5-9.
2. Kulkarni SK, Naidu PS: Tardive dyskinesia: An update. DrugsToday 2001;37:97-119.
3. Benzi G, Moretti A: Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and glutathione system. Free Radic Biol Chem 1995;19:77-101.
4. Lohr JB: Oxygen free radicals and neuropsychiatric illness. Arch Gen Psychiatry 1991;48: 1097-1106.
5. Andreassen OE, Jorgensen HA: Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Prog Neurobiol 2000;61:525-541.
6. Behl C, Lezoulach F, Widmann M, Rupprecht R, Holsboer F: Oxidative stress-resistant cells are protective against haloperidol toxicity. Brain Res 1996;717:193-195.
7. Kleeb SR, Rizzo MS, Dagli MLZ, Frussa-Filho R: Haloperidol increases spreading and nitric oxide production in macrophages from tumor-bearing mice: A possible mechanism for its antitumoral effect. Int J Immunopharmacol 1999;21:575-580.
8. Lohr JB, Kuczenski R, Bracha HS, Moir M, Jeste DV: Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol Psychiat 1990;28:535-539.
9. Nisewander JL, Castaneda E, Davis DA: Dosedependant differences in the development of reserpine-induced oral dyskinesia in rats: Support for a rat model of tardive dyskinesia. Psychopharmacology 1994;116:79-84.
10. Nisewander JL, Lucki I, McGonigle P: Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment. Brain Res 1991;558:27-35.
11. Nisewander JL, Lucki I, Mcgonigle P: Behavioural and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats. J Pharmacol Exp Ther 1991;257:850-860.
12. Nisewander JL, Castaneda E, Davis DA, Elson HJ, Sussman AN: Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia. Eur J Pharmacol 1996; 305:13-21.
13. Vital MABF, Frussa-Filho R, Palerrno-Neto J: Effects of monosialoganglioside on a new model of tardive dyskinesia. Prog Neuropsychopharmacol Biol Psychiatry 1997;21:1169-1179.
14. Süssmann AN, Tran-Nguyen LTL, Neisewander JL: Acute reserpine administration elicits long-term spontaneous oral dyskinesia. Eur J Pharmacol 1997;337:157-160.
15. Queiroz CMT, Frussa-Filho R: Effects of busporone on an animal models of tardive dyskinesia. Prog Neuropsychopharmacol Biol Psychiatry 1999;23:1405-1418.
16. Uhrbrand L, Faurbye A: Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy. Psychopharmacology 1960;1:108-418.
17. Bergamo M, Abilio VC, Queiroz CMT, Barbosa HM Jr, Abdanur LRA, Frussa-Filho R: Effects of age on a new animal model of tardive dyskinesia. Neurobiol Aging 1997;18:623-629.
18. Stip E: The heterogeneity of memory dysfunction in schizophrenia. Can J Psychiatry 1996;42 (suppl 2):S27-S34.
19. Gallhofer B, Bauer U, Kriger S, Gruppe H: Cognitive dysfunction in schizophrenia: Comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. Eur Neuropsychopharmacol 1996;6(suppl 2): S13-S20.
20. Krabbendam L, van Harten PN, Picus I, Jolles J: Tardive dyskinesia is associated with impaired retrieval from long-term memory: The Curacao Experimental Syndromes study. Part IV. Schizophr Res 2000;42:41-46.
21. Waddington JL, Youssef HA: An unusual cluster of tardive dyskinesia in schizophrenia: Association with cognitive dysfunction and negative symptoms. Am J Psychiatry 1996;143: 1162-1165.
22. Sorokin JE, Giordani B, Mohs RC, Losonczy MF, Davidson M, Siever LJ, Ryan TA, Davis KL: Memory impairment in schizophrenic patients with tardive dyskinesia. Biol Psychiatry 1988;23:129-135.
23. Pourcher E, Cohen H, Cohen D, Baruch P, Bouchard RH: Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia. Brain Cogn 1993;23:81-87.
24. Silva RH, Abilio VC, Torres-Leite D, Bergamo M, Chinen CC, Claro FT, de Cassia Carvalho R, Frussa-Filho R: Concomitant development of oral dyskinesia and memory deficits in reserpinetreated male and female mice. Behav Brain Res 2002;132:172-177.
25. Bors W, Heller W, Michel C, Saran M: Flavonoids as antioxidants: Rate constants for reaction with oxygen radicals. Method Enzymol 1994;234:420-429.
26. Afanas'ev IB, Dorozhko AI, Brodskii AW, Korstyuk VA, Potapovitch AI: Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol 1989;38:1763-1768.
27. Da Silva EL, Piskula MK, Yamamoto N, Moon J-H, Terao J: Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma. FEBS Lett 1998;430:405-408.
28. Fiorani M, De Sanctis R, Menghinello P, Cucchiarini L, Cellini B, Dacha M: Quercetin prevents glutathione depletion induced by dehydroascorbic acid in rabbit red blood cells. Free Radic Res 2001;34:639-648.
29. Graefe EU, Derendrof H, Veit M: Pharmaokinetics and bioavailability of the flavonol quercetin in humans. Int J Clin Pharmacol Ther 1999;37:219-233.
30. De Whalley CV, Rankin JF, Rankin SM: Flavonoids inhibit the oxidative modification of low density lipoproteins. Biochem Pharmacol 1990;39:1743-1749.
31. Kaul TN, Middleton E Jr, Ogra PL: Antiviral effect of flavonoids on human viruses. J Med Virol 1985;15:71-79.
32. Bronner C, Landry Y: Kinetics of the inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Actions 1985;16:147-151.
33. Queiroz CMT, Piovezan RD, Frussa-Filho R: Reserpine does not induce orofacial dyskinesia in spontaneously hypertensive rats. Eur J Pharmacol 1998;356:105-108.
34. Raghavendra V, Naidu PS, Kulkarni SK: Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: Involvement of peripheral benzodiazepine receptors. Brain Res 2001;904:149-152.
35. Naidu PS, Kulkarni SK: Reversal of reserpine-induced vacuous chewing movements by ethanol: Possible GABA-A receptor modulation. Brain Pharmacol 2002;1:189-195.
36. Naidu PS, Kulkarni SK: Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements. Eur J Pharmacol 2001;428:81-86.
37. Naidu PS, Kulkarni SK: Possible involvement of prostaglandins in haloperidol-induced orofacial dyskinesia in rats. Eur J Pharmacol 2001;430:295-298.
38. Naidu PS, Kulkarni SK: Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): Possible involvement of calcium and nitric oxide. Behav Pharmacol 2001;12:209-216.
39. Naidu PS, Singh A, Kulkarni SK: Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: Possible antioxidant mechanisms. Br J Pharmacol 2002;136:193-200.
40. Reddy DS, Kulkarni SK: Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment. Brain Res 1998; 799:215-229.
41. Ioth J, Nabeshima T, Kameyama T: Utility of an elevated plus-maze for dissociation of amnesic and behavioural effects of drugs in mice. Eur J Pharmacol 1991;194:71-74.
42. Raghavendra V, Kulkarni SK: Possible antioxidant mechanism in melatonin reversal of aging and chronic ethanol-induced amnesia in plus-maze and passive avoidance memory tasks. Free Radic Biol Med 2001;30:595-602.
43. Wills ED: Mechanism of lipid peroxide formation in animal tissues. Biochem J 1966;99:667-676.
44. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
45. Kono Y: Generation of superoxide radical during autooxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 1978;186:189-195.
46. Luck H: Catalase; in Bergmeyer HU (ed): Methods of Enzymatic Analysis. New York, Academic Press, 1971, pp 885-893.
47. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
48. Clavente PRV, Araujo CCS, Bergamo M, Abilio VC, D'Almeida V, Ribeiro RDA, Frussa-Filho R: The mitochondrial toxin 3-nitropro-pionic acid aggravates reserpine-induced oral dyskinesia in rats. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:401-405.
49. Abilio VC, Araujo CCS, Bergamo M, Clavente PRV, D'Almeida V, Ribeiro RDA, Frussa-Filho R: Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio (GSSG/ GSH) enhancement in rats. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:109-114.
50. Burger ME, Alves A, Callegari L, Athayde FR, Nogueira CW, Zen G, Rocha JBT: Ebselen attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27:135-140.
51. Dewolfe AS, Ryan JJ, Wolf ME: Cognitive squeal of tardive dyskinesia. J Nerv Ment Dis 1988;176:270-274.
52. Waddington JL, Youssef HA, Dolphin C, Kinsella A: Cognitive dysfunction, negative symptoms and tardive dyskinesia in schizophrenia: Their association in relation to topography of involuntary movements and criteriation of their abnormality. Arch Gen Psychiatry 1987;44:907-912.
53. Wolf ME, DeWolfe AS, Mosnaim AD: Cognitive deficits and tardive dyskinesia; in Yassa R, Nair NPV, Jeste DV (ed): Neuroleptic-Induced Movement disorders. New York, Cambridge University Press, 1997, pp 196-206.
54. Lohr JB, Cadet JL, Lohr MA, Larson L, Wasli E, Wade L, Hylton R, Vidoni C, Jeste DV, Wyatt RJ: Vitamin E in the treatment of tardive dyskinesia: The possible involvement of free radical mechanisms. Schizophr Bull 1988;14:291-296.
55. Reiter RJ: Oxidative processes and antioxidative defense mechanisms in the ageing brain. FASEB J 1995;9:526-533.
56. Arendt T, Allen Y, Sinden J, Schugens MM, Merchbanks RM, Lantos PL, Gray JA: Cholinergic-rich brain transplants reverse alcohol-induced memory deficits. Nature 1988;332: 448-450.
57. Socci DJ, Crandall BM, Arendash GW: Chronic antioxidant treatment improves the cognitive performance of aged rats. Brain Res 1995;693:88-94.
58. Carney JM, Stake-Reed PE, Oliver CN, Landum RW, Cheng MS, Wu JF, Floyd FA: Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of spin trapping compound N-tert-butyl-α-phenylnitrone. Proc Natl Acad Sci USA 1991;88:3633-3636.
59. Moss HB, Tamkin E, Makchrowicz E: Pineal function during ethanol intoxication, dependence and withdrawal. Life Sci 1986;39:2209-2214.
60. Robak J, Gryglewski RJ: Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 1988;37:837-841.
61. Nagata H, Takekoshi S, Honma T, Watanable K: Antioxidative action of flavonoids, quercetin and catechin, mediated by the activation of glutathione peroxidase. Tokai J Exp Clin Med 1999;24:1-11.
62. Erden Inal M, Kahraman A, Koken T: Beneficial effects of quercetin on oxidative stress induced by ultraviolet A. Clin Exp Dermatol 2001;26:536-539.
63. Aherne SA, O'Brien NM: Protection by the flavonoids myricetin, quercetin, and rutin against hydrogen peroxide-induced DNA damage in Caco-2 and Hep G2 cells. Nutr Cancer 1999; 34:160-166.
64. Sanderson J, McLauchlan WR, Williamson G: Quercetin inhibits hydrogen peroxide-induced oxidation of the rat lens. Free Radic Biol Med 1999;26:639-645.
65. Chen YC, Shen SC, Lee WR, Hou WC, Yang LL, Lee TJ: Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expression by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. J Cell Biochem 2001;82:537-548.
66. Raso GM, Meli R, Di Carlo G, Pacilio M, Di Carlo R: Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci 2001;12:921-931.
67. Lee MH, Lin RD, Shen LY, Yang YY, Yen KY, Hou WC: Monoamino oxidase B and free radical scavenging activities of natural flavonoids in Melastoma candidum D. Don. J Agric Food Chem 2001;49:5551-5555.